Djesika Amendah

Arlette Campbell White
Ann Ithibu and Alan Whiteside
On the heels of extraordinarily successful results announced by four coronavirus disease 2019 (COVID-19) vaccine developers within three weeks of one another, the question of whether developing countries will be āleft behindā continues. COVAX (one of the three pillars of the Access to COVID-19 Tools (ACT) Accelerator), a massively funded global collaboration involving 187 countries, aims to ensure that they…
Dear Reader,
The site is in a transition period and some content may not be available as the update is undergoing. Kindly bear with us.
Subscribe to ourĀ newsletter below and never miss the latest updates.
Subscribe to our weekly newsletter below.
Time to take stock of the Global Fundās Challenging Operating Environment Policy
Aidspan